<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" lang="en-US">
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
    <title>soapnote.org = calculators + decision tools + SOAP samples</title>
    <link rel="stylesheet" href="../../lib/style.css" type="text/css" media="all"/>
    <script type="text/javascript" src="../../lib/jquery.min.js"></script>
    <script type="text/javascript" src="../../lib/jquery-ui.min.js"></script>
    <script>
        function copyToClipboard(element) {
                $("body").append("<textarea id='temp' style='position:absolute;opacity:0;'></textarea>");
                $("#temp").val($(element).val()).select();
                document.execCommand("copy");
                $("#temp").remove();
                alert('Result has been copied!');
        }
    </script>
    </head>
    <body>

        <div id="container" class="embed_client">
                <!-- <h1 class="entry-title">hepatitis-b-chronic</h1> -->
                <div class="form-view-content ">
                        <form id="form_1" method="get" autocomplete="off">
                                <input type="hidden" class="input_permalink" name="input_permalink" value=""/>Chronic Hepatitis B Decision Tool<span class="exclude"><br>Summary: A decision tool for initial management of Chronic Hepatitis B.<br>See SOAPnote's Hepatitis B <a href="http://www.soapnote.org/infectious/hepatitis-b-screening/">Screening Decision Tool</a> and <a href="http://www.soapnote.org/infectious/hepatitis-b-chronic/">Chronic Decision Tool</a>.<br>Evaluation of <strong>Chronic Hepatitis B</strong> should include a thorough history and physical examination, with special emphasis on risk factors for coinfection, alcohol use, and family history of HBV infection and liver cancer. Laboratory tests should include ALT, quantified Hepatitis B viral DNA, Hepatitis B e antigen, and tests for coinfection with HCV, HDV, or HIV in those at risk.</span><br><select name="Q1"><option value="negative=0">negative</option><option value="positive=100">positive</option></select> <-- HBeAg - Hepatitis B e antigen<br><select name="Q2"><option value="less than Upper Limit of Normal (ULN)=0">less than Upper Limit of Normal (ULN)</option><option value="1 to 2 times the Upper Limit of Normal (ULN)=10">1 to 2 times the Upper Limit of Normal (ULN)</option><option value="more than 2 times the Upper Limit of Normal (ULN)=20">more than 2 times the Upper Limit of Normal (ULN)</option></select> <-- ALT - alanine aminotransferase<br><select name="Q3"><option value="less than 2000=0">less than 2000</option><option value="2,000 to 20,000=1">2,000 to 20,000</option><option value="more than 20,000=2">more than 20,000</option></select> <-- Hepatitis B virus DNA level (units = IU/mL)<br><span class="calc">Interpretation<span class="calc_value">score=(Q1)+(Q2)+(Q3);score>121?'Active phase.  Should be offered treatment.  Liver biopsy may not be necessary.  Screening is often recommended for patients at risk for developing hepatocellular carcinoma.  This includes patients over 40 years with ALT elevation and/or HBV DNA level above 2,000 IU/mL.  Alpha-fetoprotein (AFP) alone or AFP and ultrasound every 6-12 months are two options.  ':score>120?'Check ALT and HBeAg every 1-3 months.  Treat if HBeAg persists.  Liver biopsy optional.  Treat immediately if jaundice or decompensated.  Screening is often recommended for patients at risk for developing hepatocellular carcinoma.  This includes patients over 40 years with ALT elevation and/or HBV DNA level above 2,000 IU/mL.  Alpha-fetoprotein (AFP) alone or AFP and ultrasound every 6-12 months are two options.  ':score>119?'Check ALT and HBeAg every 1-3 months.  Treat if HBeAg persists.  Liver biopsy optional.  Treat immediately if jaundice or decompensated.  Screening is often recommended for patients at risk for developing hepatocellular carcinoma.  This includes patients over 40 years with ALT elevation and/or HBV DNA level above 2,000 IU/mL.  Alpha-fetoprotein (AFP) alone or AFP and ultrasound every 6-12 months are two options.  ':score>111?'Active phase.  Should be offered treatment.  Liver biopsy may not be necessary.  Screening is often recommended for patients at risk for developing hepatocellular carcinoma.  This includes patients over 40 years with ALT elevation and/or HBV DNA level above 2,000 IU/mL.  Alpha-fetoprotein (AFP) alone or AFP and ultrasound every 6-12 months are two options.  ':score>110?'Check ALT every 3 months.  Check HBeAg every 6 months.  If HBeAg persists or age greater than 40, consider biopsy.  Treat as indicated.  Screening is often recommended for patients at risk for developing hepatocellular carcinoma.  This includes patients over 40 years with ALT elevation and/or HBV DNA level above 2,000 IU/mL.  Alpha-fetoprotein (AFP) alone or AFP and ultrasound every 6-12 months are two options.  ':score>109?'Check ALT every 3 months.  Check HBeAg every 6 months.  If HBeAg persists or age greater than 40, consider biopsy.  Treat as indicated.  Screening is often recommended for patients at risk for developing hepatocellular carcinoma.  This includes patients over 40 years with ALT elevation and/or HBV DNA level above 2,000 IU/mL.  Alpha-fetoprotein (AFP) alone or AFP and ultrasound every 6-12 months are two options.  ':score>101?'Consider liver biopsy examination, particularly if patient is > 35-40 years.  Treat if disease.  If no biopsy, observe for increase in ALT levels.  Screening is often recommended for patients at risk for developing hepatocellular carcinoma.  This includes patients over 40 years with ALT elevation and/or HBV DNA level above 2,000 IU/mL.  Alpha-fetoprotein (AFP) alone or AFP and ultrasound every 6-12 months are two options.  ':score>100?'No treatment.  Monitor ALT and HBV DNA every 6-12 months.  Consider therapy in patients with known significant histologic disease.  Screening is often recommended for patients at risk for developing hepatocellular carcinoma.  This includes patients over 40 years with ALT elevation and/or HBV DNA level above 2,000 IU/mL.  Alpha-fetoprotein (AFP) alone or AFP and ultrasound every 6-12 months are two options.  ':score>99?'No treatment.  Monitor ALT and HBV DNA every 6-12 months.  Consider therapy in patients with known significant histologic disease.  ':score>21?'Active phase.  Should be offered treatment.  Liver biopsy may not be necessary.  Screening is often recommended for patients at risk for developing hepatocellular carcinoma.  This includes patients over 40 years with ALT elevation and/or HBV DNA level above 2,000 IU/mL.  Alpha-fetoprotein (AFP) alone or AFP and ultrasound every 6-12 months are two options.  ':score>20?'Should be offered treatment.  Liver biopsy may not be necessary.  Screening is often recommended for patients at risk for developing hepatocellular carcinoma.  This includes patients over 40 years with ALT elevation and/or HBV DNA level above 2,000 IU/mL.  Alpha-fetoprotein (AFP) alone or AFP and ultrasound every 6-12 months are two options.  ':score>19?'Monitor ALT & HBV DNA.  A liver biopsy may be helpful.  Screening is often recommended for patients at risk for developing hepatocellular carcinoma.  This includes patients over 40 years with ALT elevation and/or HBV DNA level above 2,000 IU/mL.  Alpha-fetoprotein (AFP) alone or AFP and ultrasound every 6-12 months are two options.  ':score>11?'Active phase.  Should be offered treatment.  Liver biopsy may not be necessary.  Screening is often recommended for patients at risk for developing hepatocellular carcinoma.  This includes patients over 40 years with ALT elevation and/or HBV DNA level above 2,000 IU/mL.  Alpha-fetoprotein (AFP) alone or AFP and ultrasound every 6-12 months are two options.  ':score>10?'Should be offered treatment.  Liver biopsy may not be necessary.  Screening is often recommended for patients at risk for developing hepatocellular carcinoma.  This includes patients over 40 years with ALT elevation and/or HBV DNA level above 2,000 IU/mL.  Alpha-fetoprotein (AFP) alone or AFP and ultrasound every 6-12 months are two options.  ':score>9?'Monitor ALT & HBV DNA every 3 months.  Consider biopsy if persistent.  Treat as indicated.  Screening is often recommended for patients at risk for developing hepatocellular carcinoma.  This includes patients over 40 years with ALT elevation and/or HBV DNA level above 2,000 IU/mL.  Alpha-fetoprotein (AFP) alone or AFP and ultrasound every 6-12 months are two options.  ':score>1?'Consider liver biopsy.  Treat if disease present.  If no biopsy, observe for rise in ALT.  Check ALT in 3 months or less.  Screening is often recommended for patients at risk for developing hepatocellular carcinoma.  This includes patients over 40 years with ALT elevation and/or HBV DNA level above 2,000 IU/mL.  Alpha-fetoprotein (AFP) alone or AFP and ultrasound every 6-12 months are two options.  ':score>0?'Inactive phase.  Treatment not indicated.  Liver biopsy not indicated.  Monitor ALT every 6-12 months for reactivation.  Screening is often recommended for patients at risk for developing hepatocellular carcinoma.  This includes patients over 40 years with ALT elevation and/or HBV DNA level above 2,000 IU/mL.  Screening with alpha-fetoprotein (AFP) alone or AFP and ultrasound every 6-12 months are two options.':'Inactive phase.  Treatment not indicated.  Monitor ALT every 3 months for 3 times.  Then monitor every 6-12 months for reactivation.'</span></span><br><span class="exclude"><hr></span><span class="checkbox" name="footnotes"> <label><input type="checkbox" name="footnotes" value="" /> </label></span><span class="memo exclude">display/hide footnotes</span><span name="conditional_560f539c66419" class="hidden"><span class="exclude"><br>reference:  AFP article on diagnosis and treatment of hepatitis B: <a href="http://www.aafp.org/afp/2010/0415/p965.html">Wilkins (2010) Am Fam Phys 81: 965-72</a>, American Association for Study of Liver Diseases (AASLD) <a href="http://www.aasld.org/practiceguidelines/Pages/default.aspx">Hepatitis B Guidelines</a>, Article with a slightly different algorithm <a href="http://www.ncbi.nlm.nih.gov/pubmed/18845489">Keefe (2008) Clin Gastroenterol Hepatol 12:1315-41</a>.<br>posted by:  Mark Morgan, M.D.<br>post/review dates:  September 11, 2011; September 1, 2015<br>revision history: <a href="https://github.com/soapnote/SOAPnote-site/tree/master/generator/txt/infectious/hepatitis-b-chronic.txt" target="_blank">www.github.com/soapnote/SOAPnote-site/tree/master/generator/txt/infectious/hepatitis-b-chronic.txt</a><br>markup link:  <a href="http://www.soapnote.org/generator/txt/infectious/hepatitis-b-chronic.txt" target="_blank">www.soapnote.org/generator/txt/infectious/hepatitis-b-chronic.txt</a></span></span><input type="button" class="soapnote_submit exclude" value="Submit"/>
<div class="soapnote_result_container exclude">
Result - Copy or Print this text:
<div class="result_buttons">
<a  onclick="copyToClipboard('.soapnote_result')" rel="nofollow" title="Copy to clipboard" href="javascript:void(0)" class="button copy-button exclude">Copy</a>
<a rel="nofollow" title="Print" href="javascript:void(0)" class="button print-button exclude">Print</a>
</div>
<textarea class="soapnote_result exclude" cols="80" rows="12" onclick="this.focus();this.select();" readonly="readonly"></textarea>
</div>
</form>
<script type="text/javascript">
if (typeof vars == 'undefined') vars = new Array();
vars[1] = {};
if (typeof conditions == 'undefined') conditions = new Array();
conditions[1] = new Array();
conditions[1].push({logic:"(footnotes).is('')", show:"conditional_560f539c66419"});
jQuery(document).ready(function($) {
				$('#form_1').find('input[name="footnotes"], select[name="footnotes"]').change(function() {
					if ($(this).attr('type') == 'checkbox') {
						vars[1][$(this).attr('name')] = new Array();
						$(this).parents('.checkbox').find(':checked').each(function() {
							vars[1][$(this).attr('name')].push($(this).val());
						});
					}
					else vars[1][$(this).attr('name')] = $(this).val();
					$.each(conditions[1], function(index, condition) { 
						$.each(vars[1], function(index, value) { 
							condition.logic = condition.logic.replace(new RegExp('\\('+index+'\\)', 'g'), 'vars[1][\''+index+'\']');
						});
						
						try {
							if (eval(condition.logic) === true) $('#form_1 [name="'+condition.show+'"]').removeClass('hidden');
							else $('#form_1 [name='+condition.show+']').addClass('hidden');
							}
						catch(err) {
							$('#form_1 [name='+condition.show+']').addClass('hidden');
						}
					});
				});
				$('#form_1').find('input[name="footnotes"], select[name="footnotes"]').change();
			});
			</script>

<script type="text/javascript">

jQuery(document).ready(function($){
$(".print-button").click(function(){
                doPrint($(this).parents('.soapnote_result_container').find('.soapnote_result').val().replace(/\n/g,"\r\n"));
        });
});
</script>
<script type="text/javascript" src="../../lib/form.js"></script>
</div>
</div>
</body>
</html>
